May 17th, 2012
Information sourced from Journal Watch:
NAMS 2012 Position Statement on Postmenopausal Hormone Therapy
Data continue to support the benefits of HT for symptom management and fracture risk reduction.
The North American Menopause Society (NAMS
May 16th, 2012
Study Question:
What is the relative value of bariatric surgery compared to medical therapy for glycemic control in type 2 diabetes mellitus?
Methods:
STAMPEDE was a randomized controlled single-center trial comparing the efficacy of inten
May 15th, 2012
Highlights how Codexis platform enables breakthrough biocatalytic processes
REDWOOD CITY, Calif.--(CRWENewswire)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and phar
May 15th, 2012
NEW YORK, May 15, 2012 (CRWENewswire)-- Capital Trust, Inc. (NYSE:CT) (the "Company") announced today that its Board of Directors (the "Board") has formed a Special Committee of the Board comprised of independent directors (the "Special Committee
May 15th, 2012
The FDA recently approved Prevnar 13® for use in adults aged 50 years and older for the prevention of pneumonia and invasive disease caused by the serotypes included in the vaccine.
The most common clinical presentation of pneumococcal disease PD
May 14th, 2012
A neuropsychological test captures the episodic memory deficit associated with AD, even early in the disease process.
Relatively brief and easy-to-perform neuropsychological tests that are valid and sensitive are important clinical tools for diagn